European Journal of Immunology

Cellular and molecular mechanisms of anti‐fungal innate immunity at epithelial barriers: the role of C‐type lectin receptors


Immune checkpoint molecules in pregnancy: Focus on regulatory T cells


CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma


Bcl6 modulates innate immunity by controlling macrophage activity and plays critical role in experimental autoimmune encephalomyelitis


Presence, function, and regulation of IL‐17F‐expressing human CD4+ T cells


Neutrophils suppress mucosal‐associated invariant T cells in humans


Overexpression of GILZ in macrophages limits systemic inflammation while increasing bacterial clearance in sepsis in mice


cDC2 and plasmacytoid dendritic cells diminish from tissues of patients with non‐Hodgkin orbital lymphoma and idiopathic orbital inflammation


CD5 blockade enhances ex vivo CD8+ T cell activation and tumour cell cytotoxicity


Identifying the inheritable component of human thymic T cell repertoire generation in monozygous twins


Immunology Letters

Effects of yolkin on the immune response of mice and its plausible mechanism of action


Analysis of the frequency of type 2 innate lymphoid cells and regulatory T cells in abortion-prone mice


Evaluation of Leishmania infantum pyridoxal kinase protein for the diagnosis of human and canine visceral leishmaniasis


Detection of tumor antigens and tumor-antigen specific T cells in NSCLC patients: Correlation of the quality of T cell responses with NSCLC subtype


Immunoregulatory properties of mesenchymal stem cells: Micro-RNAs


Outer membrane vesicle increases the efficacy of an influenza vaccine in a diet-induced obese mouse model


Targeting ROCK signaling in health, malignant and non-malignant diseases


Prohibitin 1 interacts with signal transducer and activator of transcription 3 in T-helper 17 cells


Activation-induced surface proteins in the identification of antigen-responsive CD4 T cells


Targeting PPAR ligands as possible approaches for metabolic reprogramming of T cells in cancer immunotherapy